- Home
- UPB vs ALX Comparison
UPB vs ALX Comparison
Compare UPB & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPB
- ALX
- Stock Information
- Founded
- UPB 2021
- ALX 1928
- Country
- UPB United States
- ALX United States
- Employees
- UPB N/A
- ALX N/A
- Industry
- UPB
- ALX Real Estate Investment Trusts
- Sector
- UPB
- ALX Real Estate
- Exchange
- UPB NYSE
- ALX Nasdaq
- Market Cap
- UPB 1.1B
- ALX 1.1B
- IPO Year
- UPB 2024
- ALX N/A
- Fundamental
- Price
- UPB $16.21
- ALX $200.44
- Analyst Decision
- UPB Strong Buy
- ALX Sell
- Analyst Count
- UPB 4
- ALX 1
- Target Price
- UPB $56.50
- ALX $125.00
- AVG Volume (30 Days)
- UPB 462.3K
- ALX 14.5K
- Earning Date
- UPB 02-14-2025
- ALX 02-10-2025
- Dividend Yield
- UPB N/A
- ALX 8.87%
- EPS Growth
- UPB N/A
- ALX N/A
- EPS
- UPB N/A
- ALX 9.25
- Revenue
- UPB $2,207,000.00
- ALX $233,399,000.00
- Revenue This Year
- UPB N/A
- ALX N/A
- Revenue Next Year
- UPB N/A
- ALX N/A
- P/E Ratio
- UPB N/A
- ALX $21.94
- Revenue Growth
- UPB 82.10
- ALX 8.52
- 52 Week Low
- UPB $14.97
- ALX $198.70
- 52 Week High
- UPB $29.46
- ALX $251.63
- Technical
- Relative Strength Index (RSI)
- UPB N/A
- ALX 26.17
- Support Level
- UPB N/A
- ALX $209.70
- Resistance Level
- UPB N/A
- ALX $216.90
- Average True Range (ATR)
- UPB 0.00
- ALX 5.85
- MACD
- UPB 0.00
- ALX -1.60
- Stochastic Oscillator
- UPB 0.00
- ALX 6.04
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.